• Carlos Manuel Ortiz-Mendoza.
• Department of Surgery, Faculty of Medicine, Hospital General Tacuba, ISSSTE, National Autonomous University of Mexico, Mexico City, Mexico.
• J Res Med Sci. 2019 Jan 1; 24: 9.

BackgroundAccording to an Anglo-Saxon study, in breast cancer survivors, there is a high prevalence of impaired fasting glucose. Our aim was to assess the impaired fasting glucose occurring in Mexican woman survivors of breast cancer.Materials And MethodsAt a general hospital in Mexico City, women with breast cancer with a surviving ≥2 years, without type 2 diabetes mellitus, were studied. The analysis included demographic and anthropometric features, time of surviving, and blood levels of lipids and glucose.ResultsThe sample was 119 women. Impaired fasting glucose happened in 53 (44.5%). In those with normal weight (n = 28), impaired fasting glucose occurred in 9 (32.1%); however, in overweight participants (n = 48), it developed in 22 (45.8%) and in obese participants (n = 43) in 22 (51.1%).ConclusionImpaired fasting glucose is usual in Mexican breast cancer survivors. It is more in obese and overweight women compared to normal weight.

5 keywords...

hide…